These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6993976

  • 1. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W, Kruszewska J, Szymchel J.
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Anginin effect in cerebovascular disorders in the light of psychological studies].
    Michalska I.
    Neurol Neurochir Pol; 1979; 13(2):141-6. PubMed ID: 377119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A, Solitro A, Arcuri P.
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV.
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic experience with Stugeron.
    Abrányi I.
    Ther Hung; 1973 Jan; 21(3-4):117-20. PubMed ID: 4806419
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vasodilator action of Stugeron on the cerebral and peripheral arteries in the light of clinical observations.
    Less E.
    Ther Hung; 1973 Jan; 21(3-4):140-5. PubMed ID: 4806424
    [No Abstract] [Full Text] [Related]

  • 14. [Rheoencephalographic findings in migrainous cephalalgia and their dynamics during treatment with stugeron].
    Tsirlin MIa.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977 Jan; 77(3):343-7. PubMed ID: 857528
    [Abstract] [Full Text] [Related]

  • 15. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Mishima Y, Kamiya K, Sakaguchi S, Kusaba A, Sakuma A.
    Angiology; 1977 Feb; 28(2):84-94. PubMed ID: 326097
    [Abstract] [Full Text] [Related]

  • 16. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
    Abrányi I, Máté.
    Ther Hung; 1976 Feb; 24(1):20-3. PubMed ID: 790631
    [No Abstract] [Full Text] [Related]

  • 17. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 18. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative evaluation of the therapeutic effectiveness of drugs of different mechanisms of action in cerebral atherosclerosis].
    Sobczyk W.
    Neurol Neurochir Pol; 1982 Jan; 16(4):245-60. PubMed ID: 7145012
    [Abstract] [Full Text] [Related]

  • 20. [Experience in the treatment of leg ulcer with Stutgeron].
    Mund-Hoym WD.
    Med Welt; 1976 Jun 18; 27(25):1251-4. PubMed ID: 933813
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.